Kaskela Law LLC is investigating Veradigm Inc. (NASDAQ: MDRX), formerly known as Allscripts Healthcare Solutions, on behalf of the company’s investors.

Since December 2023, shares of Veradigm’s common stock have declined in value from a  trading price of over $12.00 per share to a current trading price of below $7.00 per share, a decline of over $5.00 per share, or over 40% in value.

The investigation seeks to determine whether Veradigm and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to the company’s shareholders.

Veradigm shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the form on this page, for additional information about this investigation and their legal rights and options.